Whats new?

Latest News

Keep up with the latest news from research breakthroughs to company news

Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution

Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution of Proteon’s innovative bacteriophage solutions. The aim of the partnership is to bring Proteon’s bacteriophage technology to poultry producers in selected countries, with the help of DuPont’s trusted and well-recognized brand. The partnership will strengthen DuPont’s product portfolio and expand Proteon’s distribution capabilities, as well as help to further mitigate antimicrobial resistance (AMR) in farming animals.

The global threat of antimicrobial resistance inspired Proteon’s development of bacteriophage technologies. Modern analytics and omics technologies have enabled the company’s scientists to screen and identify bacteriophage candidates for specific bacterial challenges in livestock farming and aquaculture. Solutions developed by Proteon have a significant impact on feed and food safety. Proteon’s innovative technology is already in use in the poultry industry in selected European and Asian markets. Farmers benefit from using Proteon’s technology, which ensures biosecurity in the waterline and improves production efficiency and quality.

“We strongly believe that bacteriophage-based products are the future of animal health and nutrition, and will help to reduce antibiotic use in livestock farming and aquaculture. Moreover, mitigating antimicrobial resistance will have a significant impact on consumer health as well.” said Jarosław Dastych, CEO, Proteon Pharmaceuticals. “We are excited to take this next step with DuPont to bring the benefits of bacteriophage technology, as a feed additive, to poultry producers globally.”

“Proteon Pharmaceuticals is a pioneer in bacteriophage technology used in animal farming. They have been developing this technology for over 10 years. It has been tested in Europe and Asia and proven in terms of efficacy and stability,” said Aart Materboer, Business Leader, DuPont Animal Nutrition. “This technology fits with our nutribiotic approach. We are pleased to add it to our range of solutions for poultry producers.”

“The main factors for initializing and establishing the partnership were the global, recognized and appreciated brand of DuPont and the solid scientific approach of Proteon’s employees, as well as our leading position among peer companies globally.” – said Nipun Gupta, Chief Commercial Officer, Proteon Pharmaceuticals.

About Proteon Pharmaceuticals
Proteon Pharmaceuticals S.A. is a leader in bacteriophage (phage) technology for livestock farming and aquaculture. Proteon’s products modulate the microbiome, enhancing sustainability and improving performance on the farm. We have created a precision phage development platform that uses omics technologies, molecular biology, bioinformatics and artificial intelligence (AI) to create effective, reliable and safe antibacterial solutions for animal health. Proteon was the first company to develop precision bacteriophage-based feed additives to combat bacterial infections in poultry. More information can be found at www.proteonpharma.com.

About DuPont Animal Nutrition
DuPont Animal Nutrition is a market leader in nutritional health solutions with a comprehensive portfolio of feed enzymes, betaine, phytogenics and probiotics. Through the lens of nutribiosis, we invest in science and innovation to help producers improve performance, increase liveability and support welfare in the face of increasing pressure to reduce or remove antibiotics from production systems. Our capabilities are underpinned by the quality and quantity of our trials, our investment in omics technologies and microbiome research, and our collaboration with leading commercial, governmental and academic partners. www.animalnutrition.dupont.com

About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: www.dupontnutritionandbiosciences.com

About DuPont 
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets. More information can be found at www.dupont.com/.

Phages are the most numerous and oldest organisms on the planet. They are organic, natural and omnipresent in the environment. A critical part of the global microbiome, phages naturally protect animals and humans from bacteria. Controlled delivery of phages, using precision biological tools promises to reduce antibiotic usage, overcoming the growing threat of antibiotic resistant bacteria, as well as to increase sustainability in agriculture and to improve human health.

Product Overview

The right solution one click away!
Proteon Pharmaceuticals proprietary Phage Development Platform contains world class tools and processes.